THU0184 Impact of Immunogenicity on Clinical Efficacy and Administration Related Reaction in TNF Inhibitors: A Pooled-Analysis From Three Biosimilar Studies in Patients With Rheumatoid Arthritis

doi 10.1136/annrheumdis-2018-eular.4362
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Impact of TNF Inhibitors on Rheumatoid Arthritis

Inflammation and Regeneration
AllergyImmunology
2006English

AB0389 the Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses

2017English

Comparative Clinical Efficacy and Safety of the Proposed Biosimilar ABP 710 With Infliximab Reference Product in Patients With Rheumatoid Arthritis

Arthritis Research & Therapy
2020English

AB0340 Clinical Efficacy of Statins in Patients With Rheumatoid Arthritis

2017English

Clinical and Immunological Effects of the Original and Biosimilar Rituximab in Patients With Rheumatoid Arthritis

Clinical pharmacology and therapy
2019English

Bone and TNF in Rheumatoid Arthritis: Clinical Implications

RMD Open
RheumatologyAllergyImmunology
2015English

AB0439 Efficacy at Three Years of Daily Clinical Use of Iguratimod in Patients With Rheumatoid Arthritis

2017English

Studies on Sialyltransferase in Serum From Patients With Rheumatoid Arthritis.

Ensho
1986English

Effectiveness of TNF Inhibitor Treatment With Various Methotrexate Doses in Patients With Rheumatoid Arthritis: Results From Clinical Practice

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy